多样性探索：对抗疫情的三种主要手段——卫生、疫苗研发和化疗的一种服务方式。
Diversity Exploration: A Way to Serve the Three Main Weapons against Epidemics, Hygiene, Vaccine Development and Chemotherapy.
作者信息
Refrégier Guislaine, Genestet Charlotte
机构信息
Université Paris-Saclay, CNRS, AgroParisTech, Ecologie Systématique et Evolution, 91190 Gif-sur-Yvette, France.
Laboratoire de Bactériologie, Institut des Agents Infectieux, Hospices Civils de Lyon, CEDEX 04, 69317 Lyon, France.
出版信息
Microorganisms. 2022 Jul 25;10(8):1492. doi: 10.3390/microorganisms10081492.
Abstract
As highlighted by the SARS pandemic which is still ongoing, the battle against pathogens relies on three main "weapons": hygiene, vaccine development and chemotherapy strategies [...].
摘要
正如仍在持续的非典大流行所凸显的那样，对抗病原体的斗争依赖于三种主要“武器”：卫生、疫苗研发和化疗策略[...]。
相似文献
1
Diversity Exploration: A Way to Serve the Three Main Weapons against Epidemics, Hygiene, Vaccine Development and Chemotherapy.多样性探索：对抗疫情的三种主要手段——卫生、疫苗研发和化疗的一种服务方式。
Microorganisms. 2022 Jul 25;10(8):1492. doi: 10.3390/microorganisms10081492.
2
[Recent progress in mycobacteriology].[分枝杆菌学的最新进展]
Kekkaku. 2007 Oct;82(10):783-99.
3
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?牛分枝杆菌卡介苗（BCG）疫苗的多样性及接种前景：为何BCG无法预防结核病？
Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28.
4
EVOLUTION OF MYCOBACTERIUM TUBERCULOSIS AND IMPLICATIONS FOR VACCINE DEVELOPMENT.结核分枝杆菌的进化及其对疫苗研发的启示
Ethiop Med J. 2016 Apr;54(2):95-100.
5
Vaccine strategies against cystic fibrosis pathogens.针对囊性纤维化病原体的疫苗策略。
Hum Vaccin Immunother. 2016 Mar 3;12(3):751-6. doi: 10.1080/21645515.2015.1102810.
6
The Anti-tuberculosis Battle in Greece in the 1800s and 1900s.19世纪和20世纪希腊的抗结核斗争。
Cureus. 2022 Jun 16;14(6):e26023. doi: 10.7759/cureus.26023. eCollection 2022 Jun.
7
Current and novel approaches to vaccine development against tuberculosis.当前和新型结核疫苗开发方法。
Front Cell Infect Microbiol. 2012 Dec 6;2:154. doi: 10.3389/fcimb.2012.00154. eCollection 2012.
8
Antibody-mediated immunity against tuberculosis: implications for vaccine development.抗结核抗体免疫：对疫苗开发的启示。
Cell Host Microbe. 2013 Mar 13;13(3):250-62. doi: 10.1016/j.chom.2013.02.009.
9
Targets and strategies for vaccine development against SARS-CoV-2.针对 SARS-CoV-2 的疫苗研发的靶点和策略。
Biomed Pharmacother. 2021 May;137:111254. doi: 10.1016/j.biopha.2021.111254. Epub 2021 Jan 28.
10
-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice.- 载体多抗原结核疫苗增强了卡介苗免疫的 C57BL/6 和 BALB/c 小鼠对有毒力结核分枝杆菌气溶胶挑战的保护性免疫。
mBio. 2022 Jun 28;13(3):e0068722. doi: 10.1128/mbio.00687-22. Epub 2022 Jun 1.
本文引用的文献
1
Impact of pathobiological diversity of Mycobacterium tuberculosis on clinical features and lethal outcome of tuberculosis.结核分枝杆菌的病理生物学多样性对结核病临床特征和致死结局的影响。
BMC Microbiol. 2022 Feb 8;22(1):50. doi: 10.1186/s12866-022-02461-w.
2
The emergence, genomic diversity and global spread of SARS-CoV-2.SARS-CoV-2 的出现、基因组多样性和全球传播。
Nature. 2021 Dec;600(7889):408-418. doi: 10.1038/s41586-021-04188-6. Epub 2021 Dec 8.
3
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.SARS-CoV-2/COVID-19 大流行管理的潜在治疗靶点和疫苗开发：近期进展综述。
Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021.
4
COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development.COVID-19：临床特征、免疫反应和疫苗开发的现有知识。
FASEB J. 2021 Mar;35(3):e21409. doi: 10.1096/fj.202002662R.
5
Phylogenomics of reveals a new lineage and a complex evolutionary history.系统发生基因组学揭示了一个新谱系和一个复杂的进化历史。
Microb Genom. 2021 Feb;7(2). doi: 10.1099/mgen.0.000477.
6
Mathematical model of COVID-19 intervention scenarios for São Paulo-Brazil.针对巴西圣保罗的 COVID-19 干预场景的数学模型。
Nat Commun. 2021 Jan 18;12(1):418. doi: 10.1038/s41467-020-20687-y.
7
Cost-benefit of limited isolation and testing in COVID-19 mitigation.新冠病毒病缓解措施中有限隔离和检测的成本效益。
Sci Rep. 2020 Oct 29;10(1):18543. doi: 10.1038/s41598-020-75640-2.
8
Interaction between host genes and Mycobacterium tuberculosis lineage can affect tuberculosis severity: Evidence for coevolution?宿主基因与结核分枝杆菌谱系之间的相互作用可能会影响结核病的严重程度：协同进化的证据？
PLoS Genet. 2020 Apr 30;16(4):e1008728. doi: 10.1371/journal.pgen.1008728. eCollection 2020 Apr.
9
Ecology and evolution of Mycobacterium tuberculosis.结核分枝杆菌的生态学与进化。
Nat Rev Microbiol. 2018 Apr;16(4):202-213. doi: 10.1038/nrmicro.2018.8. Epub 2018 Feb 19.
10
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.潜伏性结核感染的全球负担：使用数学模型的重新估计
PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. eCollection 2016 Oct.
Zotero 插件